EULAR 2026 Baricitinib Misses Key Safety Benchmark in High-Risk RA Patients with RA have a higher risk of blood clots and serious infections with baricitinib vs older biologics, but not heart disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results